FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2016/07/007087 [Registered on: 13/07/2016] Trial Registered Retrospectively
Last Modified On: 13/07/2016
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia
Process of Care Changes 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A trial to study whether continuous oxygen given through the nose when patient is not breathing during the time when a tube is placed into his neck before surgery for maintaining anesthesia, increases the safety during intubation. 
Scientific Title of Study   Effect of supplemental oxygen by nasal cannula during apnea interval of intubation- a prospective randomized double blind trial. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nishant Sahay 
Designation  Assistant Professor 
Affiliation  AIIMS Patna 
Address  112, Type 4 Block 1, AIIMS Residential Area, Khagaul
112, Type 4 Block 1, AIIMS Residential Area, Khagaul
Patna
BIHAR
801105
India 
Phone  06122452035  
Fax    
Email  nishantsahay@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Nishant Sahay 
Designation  Assistant Professor 
Affiliation  AIIMS Patna 
Address  112, Type 4 Block 1, AIIMS Residential Area, Khagaul
112, Type 4 Block 1, AIIMS Residential Area, Khagaul
Patna
BIHAR
801105
India 
Phone  06122452035  
Fax    
Email  nishantsahay@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Nishant Sahay 
Designation  Assistant Professor 
Affiliation  AIIMS Patna 
Address  112, Type 4 Block 1, AIIMS Residential Area, Khagaul
112, Type 4 Block 1, AIIMS Residential Area, Khagaul
Patna
BIHAR
801105
India 
Phone  06122452035  
Fax    
Email  nishantsahay@gmail.com  
 
Source of Monetary or Material Support  
AIIMS Patna, Phulwarisharif, Patna, Bihar- 801505 
 
Primary Sponsor  
Name  All India Institute of Medical Sciences Patna 
Address  AIIMS Patna, Phulwarisharif, Patna 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
NISHANT SAHAY  AIIMS Patna  Modular OT, 3rd Floor, Mini Hospital Building, AIIMS Patna
Patna
BIHAR 
9431184516

nishantsahay@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
AIIMS Patna IEC Human Studies  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  no health disorders. study done to assess superiority of one position over other. 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Comparator - no supplemental nasal insufflation during laryngoscopy.  the standard practice is to give no supplemental nasal oxygen insufflation during intubation. We aim to assess benefits of supplemental oxygen insufflation.  
Intervention  Intervention - supplemental nasal oxygen insufflation during laryngoscopy.   The benefit of oxygen insufflation by nasal route during apnea of laryngoscopy needs to be compared with the usual practice of no nasal oxygen insufflation. The parameters to assess the benefit of this intervention shall be- 1. changes in desaturation safety period and 2. arterial oxygen partial pressure. 
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  40.00 Year(s)
Gender  Both 
Details  The patients shall be ASA: Grade 1 with Body Mass Index of < 25 Kg/m2  
 
ExclusionCriteria 
Details  Any lung pathology or respiratory problem
History of any heart disease or cerebrovascular disease
Pregnant patients
Anaemia (haemoglobin < 10gm/dl)
Known difficult airway or modified mallampatti score >2
Smokers.
Any contraindication for nasal prong use eg tumors, fractures, trauma.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Prolongation of time for saturation to come from 100% to 92% during laryngoscopy
2. Increase in arterial oxygen due to supplemental oxygen insufflation 
1. Arterial oxygen samples shall be taken thrice. Once before oxygenation is initiated ie time 0, then at 3 minutes of start of study and also after intubation has been confirmed.
2. After giving muscle relaxant ie. roughly 4 minutes after start of study, time taken for hemoglobin oxygen saturation to fall to 92% shall be noted.
3. Time required for saturation to recover to 100% once it has fallen to below 92% shall also be noted.  
 
Secondary Outcome  
Outcome  TimePoints 
Recovery of saturation to 100% from 92%, after initiation of positive pressure ventilation with 100% oxygen   9 minutes 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   02/11/2015 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

This study is a randomized, double blind, parallel group trial assessing the effectiveness of supplemental oxygen nasal insufflation during apneic period of laryngoscopy in the supine sniffing position, as compared to no oxygen insufflation. The primary outcome measures will be assessing increase in desaturation safety period when arterial saturation comes down to 92% after giving the muscle relaxant and also to assess effect on partial pressure of oxygen in arterial blood after intubation of this passive nasal oxygen insufflation. The secondary outcome will be compare the recovery time for oxygen saturation to reach 100% from 92% after initiation of positive pressure ventilation with 100% oxygen.  

 
Close